2016
DOI: 10.1093/humrep/dew103
|View full text |Cite
|
Sign up to set email alerts
|

Neonatal health including congenital malformation risk of 1072 children born after vitrified embryo transfer

Abstract: Educational grants for establishing and organizing the data collection have come from IBSA, Ferring, Organon, Shering-Plough and Merck. Merck Belgium funded the data collection for outcomes after vitrification between 2012 and 2015. All co-authors, except M.B., declared no conflict of interest. M.B. has received consultancy fees from Organon, Serono Symposia and Merck.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
41
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 89 publications
(46 citation statements)
references
References 46 publications
4
41
0
1
Order By: Relevance
“…In twins, neonatal outcomes including birthweight, small-for-gestational age, and prematurity rates were comparable in the vitrified and the fresh group. Furthermore, the rate of major congenital malformations in live-born neonates is comparable between the vitrified group and the fresh group in twins (2.4 vs. 2.7%; AOR: 0.51; 95% CI: 0.05-5.72) [119][120][121][122] .…”
Section: Discussionmentioning
confidence: 85%
“…In twins, neonatal outcomes including birthweight, small-for-gestational age, and prematurity rates were comparable in the vitrified and the fresh group. Furthermore, the rate of major congenital malformations in live-born neonates is comparable between the vitrified group and the fresh group in twins (2.4 vs. 2.7%; AOR: 0.51; 95% CI: 0.05-5.72) [119][120][121][122] .…”
Section: Discussionmentioning
confidence: 85%
“…An interesting retrospective study [118] analyzed the perinatal and neonatal health, adjusted for treatment variables and maternal characteristics, after 960 vitrified cycles and 1,644 fresh cycles according to the day of vitrification or fresh transfer, i.e. day 3 (cleavage stage) vs. day 5 (blastocyst stage).…”
Section: Resultsmentioning
confidence: 99%
“…Singletons, but not twins, born after vitrification showed only lower SGA rate (aOR 0.55, 95 % CI 0.34 to 0.90) in comparison with peers born after fresh ET. The embryonic stage at vitrification or at fresh transfer did not influence any perinatal outcome [118]. These data seem to suggest that both vitrification and extensive culture at blastocyst stage can act and interact on fetal/neonatal weight.…”
Section: Resultsmentioning
confidence: 99%
“…Sin embargo, podríamos preguntarnos cuál es la relevancia clínica de esto. Finalmente, este año, un informe de un grupo en Bruselas analizó 1 072 recién nacidos vivos de embarazos únicos y gemelares provenientes de embriones vitrificados en día 3 y 5, concluyendo que los parámetros de salud neonatal, incluida la prevalencia de malformaciones congénitas, eran similares o ligeramente mejores que después de la transferencia de embriones frescos (63) . Se debe tener en cuenta que la mayoría de estos estudios son observacionales y que los embriones vitrificados son siempre la segunda opción para la transferencia.…”
Section: La Preocupación Sobre Los Resultados Perinatales Y Obstétricosunclassified